Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Saxenda (liraglutide) is an FDA-approved injectable prescription medication for chronic weight management. It is manufactured by Novo Nordisk and belongs to a class of drugs called GLP-1 receptor agonists. Saxenda is approved for adults with a BMI of 30 or greater (obesity) or a BMI of 27 or greater with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. It is also approved for adolescents aged 12 and older with obesity. Saxenda is used alongside a reduced-calorie diet and increased physical activity.
Saxenda works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and food intake. When injected, liraglutide activates GLP-1 receptors in the brain's appetite control centers, reducing feelings of hunger and helping you eat less. It also slows gastric emptying, which means food stays in your stomach longer and you feel full for a longer period after eating. In clinical trials, patients using Saxenda lost an average of 7–8% of their body weight over 56 weeks when combined with diet and exercise.
Saxenda comes as a pre-filled, multi-dose injection pen (18 mg/3 mL). Each pen delivers multiple doses, and a box of 5 pens provides a 30-day supply at the maintenance dose of 3.0 mg daily.
Saxenda has a findability score of 55 out of 100, meaning it can be moderately difficult to locate in stock. While the broader GLP-1 shortage has eased since 2024, intermittent supply issues still occur at individual pharmacies. The launch of Teva's generic liraglutide in August 2025 has improved availability, and additional generic manufacturers are expected to enter the market after February 2026, which should further ease supply. Using a pharmacy locator tool like Medfinder can save you significant time by showing which nearby pharmacies currently have Saxenda or its generic in stock.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.
Several types of healthcare providers can prescribe Saxenda, including:
Telehealth providers can also prescribe Saxenda in many states, making it easier to get a prescription without an in-person visit.
No, Saxenda is not a controlled substance. It does not have a DEA schedule classification and is not considered to have abuse potential. This means it can be prescribed without the additional restrictions that apply to controlled substances, and refills are generally easier to obtain.
Most side effects are mild to moderate and tend to improve as your body adjusts to the medication. The gradual dose escalation over 5 weeks is designed to minimize gastrointestinal side effects.
Always inform your doctor about all medications you are taking before starting Saxenda.
Saxenda remains an effective FDA-approved option for chronic weight management in 2026, especially for patients who prefer a daily injection with a well-established safety profile. While newer medications like Wegovy and Zepbound may offer greater weight loss, Saxenda's growing generic availability through Teva (and additional manufacturers entering the market) is making it more accessible and affordable. If you're having trouble finding Saxenda in stock at your local pharmacy, try using Medfinder to search nearby pharmacies in real time — it can save you hours of calling around.
%2C%20Color%3DOriginal.png)
